Page last updated: 2024-08-17

triamcinolone acetonide and Age-Related Macular Degeneration

triamcinolone acetonide has been researched along with Age-Related Macular Degeneration in 144 studies

Research

Studies (144)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.08)	18.2507
2000's	109 (75.69)	29.6817
2010's	31 (21.53)	24.3611
2020's	1 (0.69)	2.80

Authors

Authors	Studies
Ando, R; Hirooka, K; Ishida, S; Kase, S; Noda, K; Saito, M	1
Balakrishnan, D; Oli, A	1
Jones, D; McAvoy, K; Thakur, RRS	1
Kawano, H; Nakamura, M; Otsuka, H; Sakamoto, T; Sonoda, S	1
Geltzer, A; Turalba, A; Vedula, SS	2
Gad, MA; Hamza, W; Shahin, M	1
Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL	1
Grover, A; Hirani, A; Lee, YW; Pathak, Y; Sutariya, V	1
Benz, MS; Brown, DM; Chen, E; Fish, RH; Kim, RY; Li, AL; Major, JC; OʼMalley, RE; Schefler, AC; Wang, R; Wong, TP; Wykoff, CC	1
Saperstein, DA; Singh, CN	1
Bunse, A; Frimpong-Boateng, A; Roider, J; Rüfer, F	1
Michels, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Varga, A; Vécsei-Marlovits, PV; Weigert, G	1
Brue, C; Chang, LK; Freund, KB; Klancnik, JM; Slakter, JS; Spaide, RF	1
Gotoh, N; Iwama, D; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yodoi, Y; Yoshimura, N	1
Harder, B; Ihloff, AK; Jonas, JB; Kreissig, I; Libondi, T; Schlichtenbrede, F; Spandau, UH; Vossmerbaeumer, U	1
Lo Giudice, G; Maritan, V; Midena, E; Piermarocchi, S; Sartore, M; Segato, T	1
Kaplan, HJ; Schaal, S; Tezel, TH	1
Fernandez-Munoz, M; Montero, JA; Ruiz-Moreno, JM; Sanabria, MR	1
Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A	1
Aue, A; Lie, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Gosławski, W; Karczewicz, D; Lubiński, W; Mozolewska-Piotrowska, K; Szych, Z	1
Amat, P; Lugo, FL; Montero, JA; Ruiz-Moreno, JM	1
Smiddy, WE	1
Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G; Zeimer, M	1
Ishikawa, K; Ito, Y; Kondo, M; Nishihara, H; Ozawa, S; Piao, CH; Terasaki, H	1
Adam, A; Bartz-Schmidt, KU; Boeyden, V; Claes, C; Eckardt, C; Eckert, T; Grisanti, S; Kaiserling, E; Pertile, G; Scharioth, GB; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E	1
Bakri, SJ; Edwards, AO; Pulido, JS; Risco, M	1
Falavarjani, KG; Modarres, M	1
Golubkina, L; Jonas, JB; Libondi, T; Rensch, F; Schlichtenbrede, F; Spandau, UH	1
Neuhann, IM; Voelker, M; Ziemssen, F	1
Avgikos, KN; Horgan, SE; Hu, K; Sivaraj, RR	1
Maberley, D	1
Kiernan, DF; Mieler, WF	1
Katome, T; Nagasawa, T; Naito, T; Shiota, H	1
Haneda, S; Kawasaki, R; Saito, K; Tsuchiya, D; Yamamoto, T; Yamashita, H	1
Dunavoelgyi, R; Pruente, C; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Hatta, Y; Ishikawa, K; Ito, Y; Nishihara, H; Ozawa, S; Terasaki, H	1
Bhavsar, AR; Bressler, NM; Brucker, AJ; Elman, MJ; Glassman, AR; Googe, JM; Stockdale, CR	1
Baklouti, K; Bouraoui, R; Chebil, A; el Matri, L; Kort, F; Mghaieth, F	1
Agostini, H; Böhringer, D; Feltgen, N; Lubrich, B; Ness, T	1
Kimura, H; Kuroda, S; Toyokawa, N	1
Jonas, JB; Tao, Y	1
Hajouli, N; Hiesch, A; Quintyn, JC	1
Kim, SJ; Toma, HS	1
Arcidiacono, B; Becerra, EM; Danzi, P; Gandolfo, F; Morescalchi, F; Nascimbeni, G; Semeraro, F	1
Cennamo, G; Cesarano, I; D'Amico, G; De Crecchio, G; Finelli, M; Forte, R	1
Bardak, Y; Cekiç, O; Yeşildağ, A	1
Arroyo, JG; Ceron, OM; Gautam, S; Kinoshita, T; Kovacs, KD; Murtha, TJ; Quirk, MT	1
Agnieszka, KT	1
Kubicka-Trzaska, A; Wilańska, J	1
Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B	1
Bonini-Filho, MA; Crispim, PT; Cunha, AS; Damico, FM; Haddad, A; Jorge, R; Maia-Filho, A; Messias, A; Oliveira, RC; Ribeiro, JA; Saliba, JB; Scott, IU; Siqueira, RC	1
Bandello, F; Giatsidis, S; Introini, U; Scotti, F; Setaccioli, M; Torres Gimeno, A	1
Cheung, CS; Devenyi, RG; Kertes, PJ; Lam, WC; Lui, A; Wong, AW	1
Hirose, S; Ishida, S; Kitamei, H; Noda, K; Saito, W; Yoshizawa, C	1
Nentwich, MM; Ulbig, MW	1
Lanzetta, P; Sarao, V; Veritti, D	1
Degenring, R; Jonas, JB; Kreissig, I	2
Holz, FG; Miller, DW	1
Degenring, R; Hugger, P; Jonas, JB; Kreissig, I; Panda-Jonas, S; Sauder, G	1
Billson, F; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM	1
Degenring, RF; Jonas, JB; Kreissig, I	3
Maranan, L; Sorenson, J; Spaide, RF	2
Akkoyun, I; Budde, WM; Degenring, RF; Jonas, JB; Kreissig, I	1
Danis, RP; Harris, A; Pratt, LM; Rechtman, E	1
Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I	1
Billson, FA; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM; Zhu, M	1
Jonas, JB	2
Campbell, I; Groenwald, C; Lancaster, E; Wong, D	1
Bleyl, U; Jonas, JB	1
Degenring, RF; Jonas, JB	2
Akkoyun, I; Degenring, RF; Friedemann, T; Jonas, JB; Kreissig, I	1
Dunbar, MT; Hunter, MA; Rosenfeld, PJ	1
Ball, M; Craig, J; Gillies, MC; Kuzniarz, M; Luo, W; Simpson, JM	1
Akkoyun, I; Degenring, RF; Jonas, JB; Kreissig, I	1
Haamann, PH; Klitgaard, TL; Larsen, M; Villumsen, JE	1
Arevalo, JF; Garcia, RA; Mendoza, AJ	1
Eandi, CM; Freund, KB; Klais, CM; Yannuzzi, LA	1
Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH; Vossmerbaeumer, U	2
Arevalo, JF; Fernández, CF; Mendoza, AJ	1
Gillies, MC; Larsson, J	2
Kak, R; Mitchell, KW; Sandhu, SS; Talks, SJ; Van de Moere, A	1
Bardak, Y; Cekiç, O; Tiğ, SU	1
Agurto-Rivera, R; Colina-Luquez, J; Diaz-Rubio, J; Fromow-Guerra, J; Jager, RD; Macky, TA; Martinez-Jardon, S; Papa-Oliva, G; Quiroz-Mercado, H; Torres-Bernal, L	1
Binder, S; Krebs, I; Stolba, U	1
Augustin, AJ; Schmidt-Erfurth, U	2
Gillies, MC; Simpson, JM; Zhu, M	1
Coupland, SG; Kertes, PJ	1
Calabria, G; Cicinelli, S; Ghiglione, D; Lai, S; Nasciuti, F; Nicolò, M	1
Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH	1
Aue, A; Geitzenauer, W; Michels, S; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Harder, B; Jonas, JB; Kreissig, I; Spandau, UH	1
Ito, M; Okubo, A; Sakamoto, T; Sonoda, Y; Yamakiri, K	1
Morescalchi, F; Ratiglia, R; Staurenghi, G; Viola, F	1
Augustin, A; Michels, S; Schmidt-Erfurth, U	1
Zarbin, M	1
Bergamini, F; Bottoni, F; Massacesi, A; Romano, M	1
Barthelmes, D; Bösch, MM; Fleischhauer, J; Helbig, H; Kurz-Levin, MM; Sutter, FK	1
Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I; Spandau, UH; Vossmerbaeumer, U	1
Ansari-Shahrezaei, S; Ergun, E; Krepler, K; Maár, N; Stur, M; Wedrich, A; Wimpissinger, B	1
Bencić, G; Konjević Pernar, S; Mandić, Z; Pentz, A; Vatavuk, Z	1
Menéndez de Lucas, JA; Morcillo Laiz, R	1
Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S	1
González Barcia, M; Lorenzo Carrero, J; Pérez Flores, I	1
Chaudhry, NL; Gandhi, JS; Jalil, A; Odat, TM; Yodaiken, M	1
Arias, L; Badia, M; Garcia-Arumi, J; Pujol, O; Ramon, JM; Rubio, M	2
Harder, B; Jonas, JB; Kamppeter, BA; Schlichtenbrede, F; Spandau, UH; Strueven, V	1
Arnaud, C; Audrey, L; Fournie, P; Leparmentier, A; Mathis, A; Quintyn, JC	1
Cheng, L; Falkenstein, I; Freeman, WR; Kozak, I; Tammewar, AM	1
Bienias, W; Nowak, JZ	1
Kak, R; Sandhu, SS; Talks, SJ; van de Moere, A	1
Barthelmes, D; Fleischhauer, JC; Helbig, H; Kurz-Levin, MM; Scherrer, M; Sutter, FK	1
Gómez-Ulla, F; López Gálvez, MI	1
Apte, RS; Kymes, SM; Schadlu, R	1
Binder, S; Goll, A; Krebs, I; Krepler, K; Stolba, U	1
Kolluru, C; Krishnadas, R; Mahalakshmi, R; Prasad, NM; Shukla, D; Vidhya, N	1
Inoue, Y; Iriyama, A; Obata, R; Takahashi, H; Tamaki, Y; Yanagi, Y	1
Bressler, NM; Gilson, MM; Jabs, DA; Solomon, SD; Thorne, JE; Wilson, DJ	1
Krishnan, R; Kumar, N; Wishart, PK	1
Brajac, I; Loncarek, K; Stalekar, H	1
Chaudhary, V; Hooper, PL; Mao, A; Sheidow, TG	1
Colucciello, M	1
Bartz-Schmidt, KU; Eckardt, C; Grisanti, S; Kaiserling, E; Mohr, A; Pertile, G; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E	1
Allingham, RR; Fekrat, S; Im, L; Singh, I; Stinnett, S	1
Nehemy, MB; Nehemy, PG; Schachat, AP; Vasconcelos-Santos, DV	1
Billson, FA; Challa, JK; Gillies, MC; Gyory, JF; Hunyor, AB; Penfold, PL	1
Beaumont, PE; Wingate, RJ	1
Anliker, W; Ciulla, TA; Danis, RP; Pratt, LM	1
Gillies, MC; King, NJ; Madigan, MC; Penfold, PL; Provis, JM; Wen, L	1
Billson, FA; Gyory, J; Penfold, PL; Wong, JG	1
Billson, FA; Gyory, JF; Hunyor, AB; Penfold, PL	1

Reviews

13 review(s) available for triamcinolone acetonide and Age-Related Macular Degeneration

Article	Year
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. The Cochrane database of systematic reviews, 2013, Jan-31, Issue:1 Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide	2013
The use of intraocular corticosteroids. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:15 Topics: Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Drug Implants; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis; Vitreous Body	2009
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration. Current drug targets, 2011, Volume: 12, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blindness; Choroidal Neovascularization; Combined Modality Therapy; Delayed-Action Preparations; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Vascular Endothelial Growth Factors; Verteporfin; Wet Macular Degeneration	2011
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy. Deutsches Arzteblatt international, 2012, Volume: 109, Issue:37 Topics: Adrenal Cortex Hormones; Biological Availability; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Posterior Eye Segment; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis, Posterior	2012
[Pharmacological therapy for age-related macular degeneration. Current developments and perspectives]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:2 Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Proteins; Fluorescein Angiography; Fundus Oculi; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Matrix Metalloproteinase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Photochemotherapy; Placebos; Proteins; Rats; Serpins; Time Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Visual Acuity	2003
[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide]. Klinische Monatsblatter fur Augenheilkunde, 2003, Volume: 220, Issue:6 Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Retinal Neovascularization; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body	2003
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2004, Volume: 101, Issue:2 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body	2004
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta ophthalmologica Scandinavica, 2005, Volume: 83, Issue:6 Topics: Choroidal Neovascularization; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body	2005
Perspectives on verteporfin therapy combined with intravitreal corticosteroids. Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:4 Topics: Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body	2006
Should corticosteroids be considered as part of the standard care with photodynamic therapy? Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:4 Topics: Choroidal Neovascularization; Combined Modality Therapy; Delivery of Health Care; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body	2006
Drugs for some common eye disorders. Treatment guidelines from the Medical Letter, 2007, Volume: 5, Issue:53 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc	2007
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies]. Postepy higieny i medycyny doswiadczalnej (Online), 2007, Volume: 61 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide	2007
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4 Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide	2007

Trials

31 trial(s) available for triamcinolone acetonide and Age-Related Macular Degeneration

Article	Year
Impact of intravitreal triamcinolone acetonide versus intravitreal bevacizumab on retrobulbar hemodynamic in patients with diabetic macular edema. Cutaneous and ocular toxicology, 2014, Volume: 33, Issue:1 Topics: Aged; Angiography; Antibodies, Monoclonal, Humanized; Bevacizumab; Blood Flow Velocity; Diabetic Retinopathy; Female; Hemodynamics; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography, Doppler, Color	2014
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study. The British journal of ophthalmology, 2008, Volume: 92, Issue:10 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2008
Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration. Ophthalmic research, 2009, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Injections, Intralesional; Intraocular Pressure; Macular Degeneration; Male; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity	2009
Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atrophy; Choroidal Neovascularization; Chronic Disease; Combined Modality Therapy; Drug Administration Routes; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retina; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2008
Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial. Ophthalmology, 2009, Volume: 116, Issue:11 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Double-Blind Method; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2009
Efficacy of combined photodynamic therapy and sub-Tenon's capsule injection of triamcinolone acetonide for age-related macular degeneration. The journal of medical investigation : JMI, 2009, Volume: 56, Issue:3-4 Topics: Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Connective Tissue; Female; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2009
Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone. Acta ophthalmologica, 2011, Volume: 89, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Contrast Sensitivity; Double-Blind Method; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Visual Field Tests	2011
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:12 Topics: Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Disinfection; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Incidence; Injections; Laser Coagulation; Macular Degeneration; Methicillin-Resistant Staphylococcus aureus; Povidone-Iodine; Prospective Studies; Ranibizumab; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Viridans Streptococci; Vitreous Body	2009
[Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]. Journal francais d'ophtalmologie, 2010, Volume: 33, Issue:7 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Ranibizumab; Retinal Detachment; Triamcinolone Acetonide	2010
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:5 Topics: Aged; Choroidal Neovascularization; Double-Blind Method; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Safety; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body	2003
Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2003, Volume: 110, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2003
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2004
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:3 Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Safety; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2004
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye (London, England), 2005, Volume: 19, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intralesional; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology, 2005, Volume: 112, Issue:1 Topics: Aged; Cataract; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens, Crystalline; Macular Degeneration; Male; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body	2005
Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. The British journal of ophthalmology, 2005, Volume: 89, Issue:3 Topics: Aged; Anti-Inflammatory Agents; Chi-Square Distribution; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Injections; Laser Therapy; Macular Degeneration; Male; Middle Aged; Prospective Studies; Statistics, Nonparametric; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:11 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Lasers; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide. American journal of ophthalmology, 2005, Volume: 139, Issue:6 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: a pilot study. Retina (Philadelphia, Pa.), 2005, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema. Eye (London, England), 2006, Volume: 20, Issue:12 Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Light Coagulation; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy	2006
Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]. BMC ophthalmology, 2005, Nov-25, Volume: 5 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Hyperthermia, Induced; Injections; Macular Degeneration; Pilot Projects; Prospective Studies; Pupil; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:5 Topics: Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Pilot Projects; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy	2005
Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP). Klinische Monatsblatter fur Augenheilkunde, 2006, Volume: 223, Issue:5 Topics: Aged; Angiomatosis; Anti-Inflammatory Agents; Combined Modality Therapy; Drug Combinations; Female; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Risk Assessment; Risk Factors; Treatment Failure; Treatment Outcome; Triamcinolone Acetonide	2006
Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study. Ophthalmology, 2006, Volume: 113, Issue:12 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Humans; Injections; Intraocular Pressure; Macular Degeneration; Middle Aged; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2 Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology, 2007, Volume: 114, Issue:9 Topics: Aged; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Ophthalmology, 2007, Volume: 114, Issue:12 Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Choroidal Neovascularization; Contrast Sensitivity; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Australian and New Zealand journal of ophthalmology, 1998, Volume: 26, Issue:4 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	1998
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (Philadelphia, Pa.), 2000, Volume: 20, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Pilot Projects; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2000
Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Australian and New Zealand journal of ophthalmology, 1995, Volume: 23, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Choroidal Neovascularization; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	1995

Other Studies

100 other study(ies) available for triamcinolone acetonide and Age-Related Macular Degeneration

Article	Year
Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Japanese journal of ophthalmology, 2023, Volume: 67, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Ranibizumab; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factors	2023
Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy. BMJ case reports, 2019, Sep-11, Volume: 12, Issue:9 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intravitreal Injections; Macular Degeneration; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Hemorrhage; Triamcinolone Acetonide	2019
Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery. Pharmaceutical research, 2018, Jan-16, Volume: 35, Issue:2 Topics: Administration, Ophthalmic; Biological Products; Cell Line; Diabetic Retinopathy; Drug Compounding; Drug Delivery Systems; Drug Implants; Drug Liberation; Glucocorticoids; Humans; Macular Degeneration; Materials Testing; Molecular Weight; Ovalbumin; Polyethylene Glycols; Porosity; Retinal Pigment Epithelium; Triamcinolone Acetonide	2018
Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Investigative ophthalmology & visual science, 2013, Mar-11, Volume: 54, Issue:3 Topics: Aqueous Humor; Cells, Cultured; Cytokines; Diabetic Retinopathy; Endophthalmitis; Epithelial Cells; Glucocorticoids; Granulocytes; Granuloma, Foreign-Body; Humans; Intravitreal Injections; Lens, Crystalline; Macular Degeneration; Retinal Pigment Epithelium; Retinal Vein Occlusion; Triamcinolone Acetonide	2013
Objective area measurement technique for choroidal neovascularization from fluorescein angiography. Microvascular research, 2014, Volume: 91 Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide	2014
Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration. Pharmaceutical development and technology, 2016, Volume: 21, Issue:1 Topics: Cell Line; Dose-Response Relationship, Drug; Drug Delivery Systems; Gels; Humans; Macular Degeneration; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Retinal Pigment Epithelium; Temperature; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A	2016
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics. Retina (Philadelphia, Pa.), 2016, Volume: 36, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Diabetic Retinopathy; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body	2016
Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration. Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:6 Topics: Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients. Acta ophthalmologica, 2009, Volume: 87, Issue:2 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Synergism; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2009
Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:7 Topics: Adult; Angiogenesis Inhibitors; Angioid Streaks; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Choroiditis; Drug Therapy, Combination; Female; Follow-Up Studies; Fovea Centralis; Humans; Injections; Macular Degeneration; Male; Middle Aged; Myopia, Degenerative; Photochemotherapy; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2008
Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone. The British journal of ophthalmology, 2008, Volume: 92, Issue:10 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Porphyrins; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2008
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology, 2008, Volume: 115, Issue:12 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Female; Humans; Injections; Macular Degeneration; Male; Retina; Retreatment; Retrospective Studies; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2008
Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation. The British journal of ophthalmology, 2009, Volume: 93, Issue:2 Topics: Aged; Aged, 80 and over; Drug Evaluation; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Orbit; Photochemotherapy; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2009
[Intravitreous injection: retrospective study on 2028 injections and their side effects]. Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage	2008
Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration. Acta ophthalmologica, 2010, Volume: 88, Issue:2 Topics: Choroidal Neovascularization; Combined Modality Therapy; Exudates and Transudates; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2010
[Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide]. Annales Academiae Medicae Stetinensis, 2008, Volume: 54, Issue:1 Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Fluorescein Angiography; Humans; Macular Degeneration; Retinal Neovascularization; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2008
Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization. Journal of glaucoma, 2009, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Cataract Extraction; Choroidal Neovascularization; Combined Modality Therapy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body	2009
Economic implications of current age-related macular degeneration treatments. Ophthalmology, 2009, Volume: 116, Issue:3 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Drug Therapy, Combination; Glucocorticoids; Health Care Costs; Humans; Macular Degeneration; Models, Economic; Photochemotherapy; Ranibizumab; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity	2009
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye (London, England), 2009, Volume: 23, Issue:12 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Immunologic Factors; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity	2009
Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide. Retina (Philadelphia, Pa.), 2009, Volume: 29, Issue:6 Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin	2009
Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Choroidal Neovascularization; Combined Modality Therapy; E-Selectin; Female; Humans; Immunoenzyme Techniques; Inflammation; Injections; Intercellular Adhesion Molecule-1; Laser Coagulation; Leukocyte Common Antigens; Leukocyte Count; Leukocytes; Lymphocyte Activation; Macrophages; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retina; Retrospective Studies; Thy-1 Antigens; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Bilateral simultaneous intravitreal injections in the office setting. American journal of ophthalmology, 2009, Volume: 148, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Functional Laterality; Humans; Injections; Intraoperative Complications; Macular Degeneration; Macular Edema; Office Visits; Postoperative Complications; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2009
Bevacizumab tachyphylaxis. Ophthalmology, 2009, Volume: 116, Issue:5 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Retrospective Studies; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration. Acta ophthalmologica, 2010, Volume: 88, Issue:6 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2010
Tachyphylaxis and bevacizumab. Ophthalmology, 2009, Volume: 116, Issue:8 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Tachyphylaxis and bevacizumab. Ophthalmology, 2009, Volume: 116, Issue:9 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration. Japanese journal of ophthalmology, 2009, Volume: 53, Issue:5 Topics: Aged; Asian People; Combined Modality Therapy; Connective Tissue; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Japan; Macular Degeneration; Male; Photochemotherapy; Retreatment; Retrospective Studies; Risk Assessment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2009
Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:6 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Prognosis; Prospective Studies; Retinal Detachment; Retinal Pigment Epithelium; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Toxic vitreitis outbreak after intravitreal injection. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Disease Outbreaks; Eye Diseases; Female; Humans; Injections; Macular Degeneration; Macular Edema; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Suppuration; Syringes; Triamcinolone Acetonide; Vitreous Body	2010
Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus. Japanese journal of ophthalmology, 2010, Volume: 54, Issue:2 Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fascia; Glucocorticoids; Humans; Immunocompromised Host; Injections; Macular Degeneration; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy; Vitreous Body	2010
Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Resistance; Drug Therapy, Combination; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Retina; Retreatment; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Inhibition of choroidal neovascularization by intravitreal ketorolac. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Ketorolac; Macular Degeneration; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide; Vitreous Body	2010
Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization. Acta ophthalmologica, 2010, Volume: 88, Issue:8 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Prognosis; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2010
Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration. Current eye research, 2011, Volume: 36, Issue:2 Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Choroidal Neovascularization; Ciliary Arteries; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ophthalmic Artery; Photochemotherapy; Photosensitizing Agents; Porphyrins; Regional Blood Flow; Retinal Artery; Triamcinolone Acetonide; Ultrasonography, Doppler, Color; Verteporfin; Visual Acuity	2011
A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity	2011
Transpupillary thermotherapy (TTT) with injections of triamcinolone acetonide under posterior Tenon's capsule in the treatment of exudative age-related macular degeneration (AMD). Klinika oczna, 2010, Volume: 112, Issue:10-12 Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glucocorticoids; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Poland; Tenon Capsule; Triamcinolone Acetonide; Visual Acuity	2010
[Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD) treated with transpupillary thermotherapy (TTT) alone and with transpupillary thermotherapy (TTT) combined with injection of triamcinolone acetonide (sTT Klinika oczna, 2011, Volume: 113, Issue:1-3 Topics: Aged; Aged, 80 and over; Autoantibodies; Combined Modality Therapy; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Hyperthermia, Induced; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Poland; Prospective Studies; Retina; Tenon Capsule; Triamcinolone Acetonide	2011
[Complications of intravitreal injections--own experience]. Klinika oczna, 2011, Volume: 113, Issue:4-6 Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity	2011
Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes. Current eye research, 2012, Volume: 37, Issue:1 Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intravitreal Injections; Macular Degeneration; Male; Rabbits; Retina; Triamcinolone Acetonide; Vitreous Body	2012
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012, Volume: 250, Issue:9 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ranibizumab; Retinal Detachment; Retinal Neovascularization; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity	2012
Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology, 2012, Volume: 119, Issue:8 Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Diabetic Retinopathy; Endophthalmitis; Female; Fluoroquinolones; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2012
Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Japanese journal of ophthalmology, 2013, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2013
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:4 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2013
Intraocular pressure after intravitreal injection of triamcinolone acetonide. The British journal of ophthalmology, 2003, Volume: 87, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Vitreous Body	2003
Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2002, Volume: 240, Issue:10 Topics: Aged; Drug Administration Schedule; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Triamcinolone Acetonide; Vitreous Body	2002
Intravitreal triamcinolone acetonide for exudative age related macular degeneration. The British journal of ophthalmology, 2003, Volume: 87, Issue:4 Topics: Aged; Aged, 80 and over; Cataract; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity	2003
Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:3 Topics: Aged; Aged, 80 and over; Choroid; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide	2004
Intraocular availability of triamcinolone acetonide after intravitreal injection. American journal of ophthalmology, 2004, Volume: 137, Issue:3 Topics: Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2004
Intravitreal triamcinolone acetonide for exudative age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:4 Topics: Aged; Data Interpretation, Statistical; Glucocorticoids; Humans; Injections; Macular Degeneration; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body	2004
Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye (London, England), 2004, Volume: 18, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Degeneration; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Triamcinolone Acetonide; Visual Acuity	2004
Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide. The British journal of ophthalmology, 2004, Volume: 88, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Granulocytes; Humans; Injections, Intralesional; Macular Degeneration; Triamcinolone Acetonide	2004
Serum levels of triamcinolone acetonide after intravitreal injection. American journal of ophthalmology, 2004, Volume: 137, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Vitreous Body	2004
Rinsing of the cannula prior to intravitreal injection. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:10 Topics: Catheterization; Humans; Immunosuppressive Agents; Macular Degeneration; Needles; Triamcinolone Acetonide; Vitreous Body	2004
Retinal angiomatous proliferation: clinical characteristics and treatment options. Optometry (St. Louis, Mo.), 2004, Volume: 75, Issue:9 Topics: Aged; Aged, 80 and over; Angiomatosis; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Photochemotherapy; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide	2004
Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Macula Lutea; Macular Degeneration; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Retinal Detachment; Triamcinolone Acetonide; Visual Acuity	2004
Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2005, Volume: 112, Issue:2 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2005
[Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases]. Ugeskrift for laeger, 2005, Apr-18, Volume: 167, Issue:16 Topics: Contraindications; Glucocorticoids; Humans; Injections; Macular Degeneration; Triamcinolone Acetonide; Uveitis; Vitreous Body	2005
Intravitreous triamcinolone simulating frosted retinal angiitis. Retina (Philadelphia, Pa.), 2005, Volume: 25, Issue:4 Topics: Aged; Diagnosis, Differential; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Retinal Vasculitis; Retinal Vein Occlusion; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body	2005
Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration. Clinical & experimental ophthalmology, 2005, Volume: 33, Issue:5 Topics: Aged; Blindness; Cataract; Cataract Extraction; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology, 2005, Volume: 112, Issue:11 Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Choroidal Neovascularization; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2005
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:7 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology, 2006, Volume: 113, Issue:1 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Triamcinolone for occult exudative age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 141, Issue:1 Topics: Exudates and Transudates; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body	2006
Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:1 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Eye (London, England), 2007, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2007
Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. American journal of ophthalmology, 2006, Volume: 141, Issue:2 Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pigment Epithelium of Eye; Porphyrins; Prospective Studies; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. American journal of ophthalmology, 2006, Volume: 141, Issue:3 Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2006, Volume: 220, Issue:2 Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Ptosis following an intravitreal injection of triamcinolone acetonide. Eye (London, England), 2007, Volume: 21, Issue:3 Topics: Aged; Blepharoptosis; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Triamcinolone Acetonide; Vitreous Body	2007
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 141, Issue:4 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2006
Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:11 Topics: Aged; Aged, 80 and over; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Regional Blood Flow; Retinal Neovascularization; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body	2006
Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 142, Issue:1 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
[Intravitreal application of triamcinolone--our experiences]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006, Volume: 60, Issue:2 Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
[Medical and legal issues related to the drugs currently used in the treatment of Age-Related Macular Degeneration (ARMD)]. Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:7 Topics: Aptamers, Nucleotide; Drug Utilization; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Spain; Triamcinolone Acetonide; Verteporfin	2006
Evolving European guidance on the medical management of neovascular age related macular degeneration. The British journal of ophthalmology, 2006, Volume: 90, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide	2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. American journal of ophthalmology, 2006, Volume: 142, Issue:3 Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
Inadvertent injection of triamcinolone into the crystalline lens. Eye (London, England), 2007, Volume: 21, Issue:1 Topics: Aged, 80 and over; Glucocorticoids; Humans; Injections; Lens, Crystalline; Macular Degeneration; Male; Medication Errors; Triamcinolone Acetonide	2007
Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration. Ophthalmic research, 2006, Volume: 38, Issue:6 Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retreatment; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
[Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]. Journal francais d'ophtalmologie, 2007, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroid; Combined Modality Therapy; Female; Humans; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Detachment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin	2007
Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:1 Topics: Aged; Aging; Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2007
Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. American journal of ophthalmology, 2007, Volume: 143, Issue:4 Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration. Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Exudates and Transudates; Female; Humans; Injections; Macular Degeneration; Male; Retinal Detachment; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body	2007
[Considerations about intravitreal triamcinolone use]. Archivos de la Sociedad Espanola de Oftalmologia, 2007, Volume: 82, Issue:6 Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Triamcinolone Acetonide; Vitreous Body	2007
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2007, Volume: 245, Issue:11 Topics: Choroidal Neovascularization; Combined Modality Therapy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. American journal of ophthalmology, 2007, Volume: 144, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2007
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]. Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin	2007
Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2008
Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone. American journal of ophthalmology, 2007, Volume: 144, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body	2007
Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Porphyrins; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Viscocanalostomy for refractory glaucoma secondary to intravitreal triamcinolone acetonide injection. Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:9 Topics: Aged; Female; Filtering Surgery; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Sclera; Surgical Flaps; Triamcinolone Acetonide	2007
[Subtenonial application of triamcinolone in neovascular form of senile macular degeneration]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2007, Volume: 61, Issue:4 Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Triamcinolone Acetonide	2007
Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: short-term optical coherence tomography results. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Topics: Aging; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Humans; Intraocular Pressure; Macular Degeneration; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2008
Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD34; Choroidal Neovascularization; Drug Therapy, Combination; Endostatins; Female; Humans; Immunoenzyme Techniques; Keratin-18; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin	2008
A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. Journal of glaucoma, 2008, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2008
Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body	2008
Intravitreal triamcinolone and elevated intraocular pressure. Australian and New Zealand journal of ophthalmology, 1999, Volume: 27, Issue:6 Topics: Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Ocular Hypertension; Prospective Studies; Retinal Neovascularization; Risk Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body	1999
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clinical and experimental immunology, 2000, Volume: 121, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cell Line; Cell Membrane Permeability; Epithelial Cells; Histocompatibility Antigens Class I; Humans; Intercellular Adhesion Molecule-1; Macular Degeneration; Microscopy, Electron; Tetradecanoylphorbol Acetate; Triamcinolone Acetonide	2000
Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clinical & experimental ophthalmology, 2001, Volume: 29, Issue:3 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Down-Regulation; Female; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glucocorticoids; HLA-DR Antigens; Humans; Immunohistochemistry; Injections; Macular Degeneration; Microglia; Microscopy, Confocal; Triamcinolone Acetonide; Vitreous Body	2001